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Purpose: To determine if the Schirmer I test (without anesthesia) cut-off value is a predictor of dry 
eye severity in a large Norwegian cohort of dry eye disease (DED) patients, which are grouped into 
six levels of tear production.  
 
Methods: Patients (n=1090) with DED of different etiologies received an extensive dry eye work-
up: osmolarity (Osm), tear meniscus height (TMH), tear film break-up time (TFBUT), ocular 
protection index (OPI), ocular surface staining (OSS), Schirmer I test (ST), meibum expressibility 
(ME) and meibum quality (MQ). Classification of dry eye severity level (DESL) and diagnosis of 
meibomian gland dysfunction (MGD) were also included. The cohort was divided into six groups: 
below and above cut-off values of 5 (groups 1 and 2), 10 (groups 3 and 4) and 15 mm (groups 5 and 
6) of ST. Mann-Whitney test and Chi-Square test were used for group comparison of parameters 
(P≤0.05).  
 
Results: The groups 1, 3, and 5 had values indicating more severe DED than the groups 2, 4, 6 with 
significant difference in DESL, Osm, TFBUT, OPI, OSS and TMH. Regardless of the choice of 
cut-off values, there was no statistically significant difference in ME, MQ and MGD between 
groups below and above selected cut-off value. When gender difference was considered in each 
group, significant difference was only observed for DESL (groups 2, 4 and 5), TFBUT (groups 2, 4 
and 5), OPI (groups 2 and 6) and ME (group1).  
 
Conclusions: Schirmer I is a robust discriminator for DESL, Osm, TFBUT, OPI, OSS and TMH, 
but not for ME, MQ and MGD. Patients with lower tear production levels presented with more 
severe DED at all three defined cut-off values. Interestingly, the differences in the mean values of 
DESL were minimal although statistically significant. Thus, the clinical value of different Schirmer 
levels appears to be limited.  
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Dry eye disease (DED) is a multifactorial disorder, which can be caused by an alteration in the 
quality or quantity of tear film’s three layers 1. DED can result from primary factors such as 
lacrimal gland atrophy and secondary factors such as pathological changes in the eyelids, 
conjunctiva, or cornea along with other influencing factors, including immunological processes, 
neurotransmitters, hormones, pharmaceuticals, contact lenses and environmental pollution 2-4. In 
addition to these causes, several risk factors have been proposed as contributing to the development 
of the disease: gender (i.e. female), increasing age, therapies (e.g. postmenopausal estrogen and 
radiation), dietary deficiencies (e.g. vitamin A and omega-3 fatty acids), and systemic diseases (e.g. 
hepatitis C) 5-8.  
 
Several clinical tests are available for diagnostic evaluations, clinical trials and follow-up 
examinations, including Schirmer I test (ST), measurement of tear osmolarity (Osm), tear film 
break-up time (TFBUT), ocular surface staining (OSS), tear meniscus height (TMH), meibum 
expressibility (ME) and meibum quality (MQ). Among them, ST is the most widely used method 
for assessment of aqueous tear production. It was first introduced by Schirmer in 1903 as installed 
piece of striped and marked (35 by 5 mm) blotting paper on lower eyelid margin with or without 
anesthesia to collect tears. ST suffers from several drawbacks such as poor reproducibility, 
sensitivity and specificity, long testing time (i.e. 5 min), potential for evaporative loss, high 
variability, discomfort, possibility of uneven absorption of tear by paper strip, and no well-defined 
cut-off value 9-13. Nevertheless, ST without topical anaesthesia is considered a valid 
ophthalmological test for patients with severe DED 14. To assess whether the ST can be utilized as a 
discriminator for other objective tests, we investigated clinical parameters in a large Norwegian 
cohort of 1090 dry eye disease (DED) patients grouped into six levels of tear production. The six 
groups were below and above cut-off values of 5 mm (groups 1 and 2), 10 mm (groups 3 and 4) and 




Materials and Methods 
 
Patients 
One thousand and ninety subjects (average age: 52.86 ± 16.03 years, range: 8-95, 796 females and 
294 males) diagnosed with DED of different etiologies were consecutively included in the study at 
the Norwegian Dry Eye Clinic between 2012 and 2016. All subjects received an extensive dry eye 
work-up.  
 
All examinations were carried out at the same clinic by the same ophthalmologist during normal 
working hours between 9 AM and 3 PM. The use of the data for the study has been reviewed by 
The Regional Committee for Medical & Health Research Ethics, Section C, South East Norway 
(REC). REC found the research project “Evaluation of data from the Norwegian Dry Eye Clinic” to 
be outside the remit of the Act on Medical and Health Research (2008) and therefore could be 
implemented without its approval. Prior to data collection, informed consent was obtained from all 




All subjects underwent a comprehensive ophthalmic examination by the following stepwise tests: 
osmolarity (Osm), tear meniscus height (TMH), tear film break-up time (TFBUT), ocular protection 
index (OPI), ocular surface staining (OSS), Schirmer I test (ST), meibum expressibility (ME), and 
meibum quality (MQ), classification of dry eye severity level (DESL), and diagnosis of meibomian 
gland dysfunction (MGD).  
 
The tear quality evaluation was performed using TFBUT after instillation of 5 µl 2% fluorescein 
sodium. Ocular surface staining with fluorescein was recorded after Oxford Grading Scheme: 0-15; 
range of corneal staining: 0-5) 15. Schirmer test was performed without topical anaesthesia in 5 
minutes. The calculation of OPI was based on the ratio of the TFBUT divided by the blink interval 
16. TMH was measured using a slit lamp. ME was recorded based on the number of secreted glands 
of the lower eyelid viewed at the slit lamp when light pressure applied by cotton tips on central five 
MGs (0=all five glands expressible; 1=three to four glands expressible; 2=one to two glands 
expressible; and 3=no gland expressible). For MQ, the central eight glands of the lower eyelid were 
scored on a scale of 0 to 3 for each gland (0=clear; 1=cloudy; 2=cloudy with debris (granular); and 
3=thick, like toothpaste). The sum of the central eight glands was then calculated (total score range, 
0-24). DESL was assessed according to the Behrens, et al. 17, modified by 2007 International Dry 
Eye Workshop criteria 18 (Table 1) and diagnosis of meibomian gland dysfunction (MGD) was 
based on the suggestions by the international workshop on MGD 19. Only 520 subjects were 
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examined for tear film osmolarity measurement using TearLab Osmolarity System (TearLab Corp, 
San Diego, CA).  
 
Statistical Analysis  
Data from right eye were used for statistical analysis. The cohort was divided into six groups: 
below and above cut-off values (5, 10 and 15 mm) of ST for comparisons. Mann-Whitney test and 
Chi-Square test were used for group comparison of parameters using SPSS version 21 (SPSS Inc., 
Chicago, IL, USA). Chi-Square test was used to determine if females were different from males in 
each group. Data are presented as mean and standard error. P values less than or equal to 0.05 were 





Table 2 presents the subject demographics (average age: 52.86 ± 16.03 yrs, range: 8-95). The 
number of females (n=796) was higher than males (n=294). In all groups, except age group 0-19, 
females outnumbered males. The highest number of patients belonged to age group 40-59 (n=430). 
In contrast, age groups 80-99 (n=34) and 0-19 (n=9) presented the lowest number of patients, 
respectively.  
 
Table 3 shows the distribution of Schirmer test wetting length. The overall average was 14.67 ± 
0.308 mm. Among participants, 20%, 45% and 62% had Schirmer test of <5 mm, ≤10 mm and ≤15 
mm, respectively. The percentage of fully soaked strip (≥30 mm) was 12.7%.  
 
The analysis revealed that groups 1, 3, and 5 (i.e., individuals with values below cut-off levels of ≤5 
mm, ≤10 mm, and ≤15 mm, respectively) had values indicating more severe DED with significant 
difference of p≤0.05 for DESL, Osm, TFBUT, OPI, OSS and TMH compared to the corresponding 
groups (2, 4, and 6) (Table 4). Regardless of the choice of cut-off values, there was no statistically 
significant difference in ME, MQ and MGD between the groups. The Chi-Square test indicated 
significant difference between six tear production level groups for TMH (p<0.001) in all three 
defined cut-off values but there was no significant difference for MGD (Table 4).  
 
When gender difference was considered in each group (Table 5), Chi-Square test indicated 
significant difference only for DESL (groups 2, 4 and 5), TFBUT (groups 2, 4 and 5), OPI (groups 





This study revealed that patients with lower tear production levels measured by ST presented with 
more severe DED than patients with higher tear production. All the three defined cut-off values (≤5, 
≤10 and ≤15 mm) gave rise to significant difference for DESL, Osm, TFBUT, OPI, OSS and TMH, 
but not for ME, MQ and MGD, in the six tear production level groups. There was no clear pattern 
in the gender difference of each group and significant difference was only observed for DESL 
(groups 2, 4 and 5), TFBUT (groups 2, 4 and 5), OPI (groups 2 and 6) and ME (group1).  
 
An association between ST and other commonly used clinical DED tests has previously been 
published. For example, three out of four statistical analyses performed by Nichols, et al. 20 revealed 
a significant relationship between the ST (cut-off ≤5 mm) and TFBUT (cut-off ≤10 s) in DED 
patients (n=75) compared to other objective tests. These two parameters were significantly 
correlated (r=0.40) and lower ST results were found to predict lower TFBUT in the stepwise, 
multivariate logistic regression models. Also, Wilcoxon rank sum analysis showed that subjects 
with an abnormal TFBUT had lower mean Schirmer scores.  
 
Sullivan, et al. 21 determined correlation coefficients between ST (cut-off <7 mm) and other tests: 
Osm (0.05), TFBUT (0.08), fluorescein corneal staining (0.14), lissamine green conjunctival 
staining (0.13) and Bron/Foulks meibomian gland grading (0.05) in 344 subjects with (262) and 
without (82) DED. In order to compare their results with an independent data set, the authors used 
the data collected from a previously published study in Germany with 200 subjects (184 DED and 
16 health controls) 22. Accordingly, correlation coefficients were reported between ST and other 
clinical parameters, such as Osm (0.00), TFBUT (0.06), fluorescein corneal staining (0.03), 
lissamine green conjunctival staining (0.03) and Bron/Foulks meibomian gland grading (0.03). 
These results indicate that this test of aqueous deficiency can be utilized as a discriminator for some 
other objective tests.  
 
Among all the parameters investigated in the current study, ST was unable to significantly 
discriminate only those related to meibomian gland function (ME, MQ and MGD). Patients with 
MGD have an unstable tear lipid layer but are generally considered to have normal tear production. 
This instability in the lipid layer may cause a decrease in tear volume, which in turn results in 
higher rates of evaporations and eventually damage to the ocular surface 23. In contrast, Tung, et al. 
24 observed a different pattern in MGD wherein higher tear volume correlates with worse ocular 
surface disease. Thus, the authors hypothesized that changes in tear composition such as 
hyperosmolarity, lactoferrin concentration and inflammatory mediators may play a more important 
role in causing corneal epithelial damage in MGD than increased evaporation. This may also be the 
case in our study, as ST could not significantly determine meibomian gland parameters in DED 
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patients. Therefore, measuring tear production may not be an efficient discriminator for ME, MQ, 
and MGD tests.  
 
Historically, a gradual decrease in cut-off value for ST has been observed. For example, Schirmer 
25, De Roetth 26 and Van Bijsterveld 27 used 15, 10 and 5.5 mm as normal cut-off values in their 
studies, respectively. The lack of well-defined cut-off values for the available DED tests such as ST 
complicates research making it difficult to compare results from different studies. The choice of 
cut-off value by researchers has been based on the purpose of their studies, e.g. increased sensitivity 
for screening and specificity for therapeutic purposes. Irrespective of whether the cut-off value is 
defined as 5, 10 or 15 mm, the present study showed that ST is a robust discriminator for some 
clinical DED tests in a cohort of 1090 DED individuals.  
 
For ST without anesthesia, the application of 10 mm cut-off value was considered sufficiently high 
not to overlook DED for screening purposes, but a proper value should be used to increase 
specificity in comparing inter-institutional data and evaluating efficacy of drugs even though 
sensitivity decreases to some extent 28. However, Lee and Hyun 29 suggested that there is no 
available normal cut-off value for ST due to the high number of false positive or false negative 
values, leading to the ratio of 48.4% misdiagnosis in their study. They concluded that ST was not a 
reproducible test to differentiate DED patients (n=15) from normal individuals (n=110) and 
therefore analogized ST to the toss of a coin in the diagnosis of DED. In contrast, Van Bijsterveld's 
(1969) cut-off value of 5.5 mm was suggested to be acceptable because of impossibility in ruling 
out both false positivity and false negativity in ST test due to its inaccuracy 28,30,31. In the current 
study, a possible explanation for obtaining significant differences using all three defined cut-off 
values might be related to the sample size. We recruited 1090 subjects in contrast to other studies 
with a significantly lower number of individuals. Clearly, larger sample size increases statistical 
robustness 32. Thus, by increasing the number of subjects, the conclusions may change and 
researchers should be mindful of this when designing their studies.  
 
In response to the limitations of ST, such as invasive nature, unavoidable variability, poor 
reproducibility, long testing time (i.e. 5 min), low sensitivity and specificity, alternative strategies 
have been proposed by researchers. A study evaluating the diagnostic usefulness of ST by using the 
Japanese diagnostic criteria on DED concluded that the combination of ST and TFBUT increased 
the diagnostic predictability 28. Other authors prefer to use less invasive tests, e.g. phenol red thread 
test 33 or non-invasive methods, such as thermography, keratography and Hartmann-Shack 
wavefront sensor 34-36. Nevertheless, based on our results, ST should be chosen as a clinical 




Schirmer test is a robust discriminator for DESL, Osm, TFBUT, OPI, OSS and TMH, but not for 
ME, MQ and MGD.  Our results demonstrate that patients with lower tear production levels 
presented with more severe DED, irrespective of different cut-off levels (5, 10 or 15 mm).  
Interestingly, the differences in the mean values of DESL were minimal although statistically 
significant. Thus, the clinical value of different Schirmer levels appears to be limited. No clear 
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